GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non-hormonaltopical ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

Cosmo Pharmaceuticals attracted welcome attention from investors and other market watchers after coming out with topline ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Meng Liang speaking at the 22nd World Congress of Chinese Medicine, which ran from Oct 30 to Nov 1 in Sydney. [Photo provided to chinadaily.com.cn] "We live in an era of rapid technological ...

Federal regulators have strongly urged consumers to avoid it at all costs, noting that drinking the solution is akin to ...

Many Americans use medical marijuana for chronic pain, sleep, and depression. But new research in JAMA says it may not really work. Instead, it may cause new health problems.

Glioblastoma is one of the most lethal brain cancers known, and for decades treatment has barely budged survival curves despite surgery, radiation, and chemotherapy. Now researchers are testing a ...

Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated for intrathecal administration across age groups.